Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.
management
polymyalgia rheumatica
treatment
Journal
Rheumatology advances in practice
ISSN: 2514-1775
Titre abrégé: Rheumatol Adv Pract
Pays: England
ID NLM: 101736676
Informations de publication
Date de publication:
2024
2024
Historique:
received:
25
09
2023
accepted:
28
12
2023
medline:
19
2
2024
pubmed:
19
2
2024
entrez:
19
2
2024
Statut:
epublish
Résumé
The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.
Identifiants
pubmed: 38371294
doi: 10.1093/rap/rkae002
pii: rkae002
pmc: PMC10871769
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
rkae002Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.